FDA authorizes first eyeglass lenses to slow nearsightedness in children in the US

STELLEST approved in the US by the FDA for first eyeglass lens to slow myopia

Our fellow cohort of population in the south of the border now has access to the eyeglass technology available in Canada since 2021.

FDA approved the STELLEST lens in October 2025 and many patients have now been able to access fitting their children with this technology in the past few weeks.

While MIYOSMART and MYOVISION are not released yet in the US, this is an important step in access to care for patients in the USA.

Please read the link on CNN: FDA authorizes First Eyeglass Lens to slow nearsightedness in children in the US

I Koh